Filing Details
- Accession Number:
- 0001181431-14-031916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-15 12:46:09
- Reporting Period:
- 2014-09-15
- Filing Date:
- 2014-09-15
- Accepted Time:
- 2014-09-15 12:46:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1285648 | Geert Cauwenbergh | C/O Rxi Pharmaceuticals Corporation 257 Simarano Drive, Suite 101 Marlborough MA 01752 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2014-09-15 | 5,000 | $2.18 | 36,000 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2014-09-15 | 3,000 | $2.19 | 39,000 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2014-09-15 | 2,000 | $2.19 | 41,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |